Vlad Coric insider trades

Open-market stock purchases and sales by Vlad Coric, Director at Royalty Pharma plc, from SEC Form 4 filings since Oct 31, 2017.

Track record: 58% of 19 scored buys are up 5% or more since purchase, averaging +4%.

Recent trades

DateStockTradeValue
Jun 5, 2026RPRX Royalty Pharma plcBought (not open market)—
Feb 27, 2026BHVN Biohaven LtdBought (not open market)—
Feb 5, 2026MANE Veradermics, IncBought$1M
Feb 5, 2026MANE Veradermics, IncBought (not open market)—
Feb 5, 2026MANE Veradermics, IncBought (not open market)—
Feb 5, 2026MANE Veradermics, IncBought (not open market)—
Feb 5, 2026MANE Veradermics, IncBought (not open market)—
Feb 3, 2026MANE Veradermics, IncBought (not open market)—
Jan 5, 2026BHVN Biohaven LtdSold (not open market)$73.8K
Jan 5, 2026BHVN Biohaven LtdBought (not open market)—
Nov 13, 2025BHVN Biohaven LtdBought$2.5M

Companies traded

  • RPRX Royalty Pharma plc: other filings, last Jun 5, 2026
  • BHVN Biohaven Ltd: 19 buys, 19 sales, last Feb 27, 2026
  • MANE Veradermics, Inc: 1 buy, last Feb 5, 2026
  • RVNC Revance Therapeutics, Inc: other filings, last Feb 6, 2025

Get free alerts when Vlad Coric files a new trade →